Methods. We used db/db mice that were crossed with transgenic mice expressing reduced levels of mitogen-activated protein kinase organizer 1 (MORG1), a scaffold protein interacting with prolyl hydroxylase domain 3 (PHD3), because of deletion of one MORG1 allele. Results. We found significantly reduced nephropathy in diabetic MORG1 þ/À heterozygous mice compared with the diabetic wild-types (db/dbXMORG1 þ/þ ). Furthermore, we demonstrated that EMT-like changes in the tubulointerstitium of diabetic wild-type MORG1 þ/þ mice are present, whereas diabetic mice with reduced expression of MORG1 showed significantly fewer EMT-like changes. Conclusions. These findings reveal that a deletion of one MORG1 allele inhibits the development of DN in db/db mice. The data suggest that the diminished interstitial fibrosis in these mice is a likely consequence of suppressed EMT-like changes.
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I N T R O D U C T I O N
Diabetic nephropathy (DN) is one of the most serious complications in diabetic patients and the primary cause of end-stage renal failure in many countries. It is characterized by thickening of the basement membranes and the progressive accumulation of extracellular matrix (ECM) in the mesangium and tubulointerstitium [1] . The principal effector cells that are responsible for the excess deposition of ECM and subsequent tubulointerstitial fibrosis are interstitial myofibroblasts [1, 2] . A key topic of controversy in the study of renal fibrosis has been the relative contribution of renal parenchymal cells versus non-renal cells to the myofibroblast population [2] . Several publications have incriminated epithelial-to-mesenchymal transition (EMT) of tubular cells as a key source of matrix-producing fibroblasts that drive fibrosis, demonstrating that tubular cells lose their epithelial markers (e.g. E-cadherin), acquire mesenchymal markers (e.g. a-smooth muscle actin) and undergo morphologic changes [3] [4] [5] . Some investigators have raised doubts regarding the occurrence and relevance of EMT [6, 7] , but a novel perception is that EMT reflects a more global process in the renal tissue than a complete EMT of single cells [3, [8] [9] [10] . Two elegant studies have recently described an intratubular EMT-like programme of epithelial cell dedifferentiation that may contribute to the recruitment or proliferation of interstitial myofibroblasts after kidney injury. Both research teams knocked out the zinc finger-type transcription factor snail family transcriptional repressor 1 (SNAI1) in tubules and found significant reductions in interstitial fibrosis, which highlighted the importance of an EMT-like programme in renal epithelial cells for the development of fibrosis [10, 11] . However, the EMT mechanism is highly regulated and several factors and pathways are known to drive this mechanism, where the profibrotic transforming growth factor beta 1 (TGF-b1) is the most potent inducer [1] .
Additionally, it has been shown that hypoxia and hypoxiainducible factors (HIFs) can also promote renal fibrosis and the progression of chronic kidney disease (CKD) in certain models [12, 13] . Notable discrepancies have been observed regarding the protective but also the pathogenic roles of HIFs in acute kidney diseases and CKD [13] , but the data indicate that which HIF-a isoform is activated could be important. For instance, one study has shown that renal fibrosis is predominantly associated with activation of HIF-1a, whereas reduced renal fibrosis is associated with activation of HIF-2a [14] . The primary mechanism by which HIF activity is regulated is through the oxygen-dependent proteasomal degradation of the HIF-a subunit; prolyl hydroxylation by members of the prolyl hydroxylase domain (PHD) family is required for this [13] . When PHDs are inactive, HIF-a is stabilized, can translocate into the nucleus and can transactivate a myriad of target genes [13] . We and others demonstrated a protective role of preconditioned HIF activation against hypoxiaassociated acute kidney damage [1, [15] [16] [17] . Recent data have shown that mice with increased stability and activity of HIF-1/2 showed diminished renal injury after systemic hypoxia [1] . They exhibited significantly fewer renal lesions, significantly reduced inflammation and less tubular damage and apoptosis [1] . Whereas the protective effects of HIF-regulated biological processes in acutely injured kidneys are widely accepted under longterm hypoxic conditions, such as in CKDs, HIF can mediate, at least in part, renal fibrosis and EMT in some models [12] . However, a recent publication from Nordquist et al. [18] described that pharmacologic activation of the HIF system prevents streptozotocin (STZ)-induced DN in rats. This group showed that cobalt chloride-activated HIFs prevented the diabetes-induced alterations in oxygen metabolism, mitochondrial leak respiration and kidney function and reduced proteinuria and tubulointerstitial damage [18] . On the other hand, it has been shown that cobalt is a rather non-specific PHD inhibitor and is likely to inhibit other dioxygenases, which may also act on non-HIF substrates [19] . Therefore, to address the issue of HIF dependence versus non-HIF-mediated effects, studies must use genetic models or pharmacologic approaches that target the PHD/HIF system more specifically [19] .
The mice used in this study are heterozygous for mitogenactivated protein kinase (MAPK) organizer 1 (MORG1), a molecular scaffold that directly binds prolyl hydroxylase domain 3 (PHD3), thereby increasing HIF stability [20] . These mice were crossed with mice from the db/db strain to obtain a type 2 diabetes model for DN. Here, we investigated whether db/ dbXMORG1 þ/À mice revealed fewer EMT-like changes compared with the db/dbXMORG1 þ/þ genotype. Our data revealed that a small but chronic HIF-2a activation in the kidneys of db/ dbXMORG1 þ/À mice resulted in less albuminuria, a decrease in tubulointerstitial fibrosis and fewer EMT-like changes compared with the db/dbXMORG1 þ/þ mice.
M A T E R I A L S A N D M E T H O D S

Animals
All animal experiments were approved by the local ethics committee and were done in accordance with the German Animal Protection Law. The mouse line used in this study was
generated by crossing heterozygous mice from the MORG1 strain with heterozygous mice from the db/db strain. MORG1 heterozygous mice were generated as described previously and backcrossed for !12 generations into the C57BL/6J background [15] . The db/db mice (BKS.Cg-m þ/þ Lepr db/J; C57BLKS/J background) were obtained from Charles River Laboratory (Sulzfeld, Germany). All mice were on a mixed C57BLKS/J and C57BL/6J genetic background at the second to third generation and littermates with similar genetic backgrounds were analysed. All animals were maintained in a pathogen-free facility with a 12-h light/dark cycle and were reared on standard chow and water ad libitum. Animals for experiments were selected by genotype and divided into four groups (n ¼ 8 per group): non-diabetic controls db/mXMORG1 þ/þ and db/mXMORG1 þ/À and diabetic starins db/dbXMORG1 þ/þ and db/dbXMORG1 þ/À . Mice between 23 and 26 weeks of age were placed in metabolic cages (Tecniplast, Buguggiate, Italy) to collect 24-h urine. Then mice were euthanized and blood and kidneys were removed. The kidneys were fixed in 5% phosphate-buffered formalin and embedded in paraffin for histological and immunohistochemical studies.
Haematologic and renal function parameters
To quantify the albumin:creatinine ratio, the urinary albumin was measured with an enzyme-linked immunosorbent assay (ELISA) specific for mouse albumin (Cell Trend, Luckenwalde, Germany) and urinary creatinine with a standard enzymatic assay (Cayman Chemicals, Ann Arbor, MI, USA). Mouse blood was collected for detection of the blood count using the pocH100iV DIFF instrument (Sysmex, Norderstedt, Germany). Blood serum was used for determination of erythropoietin (EPO) with an ELISA (Quantikine, R&D Systems, Wiesbaden, Germany). Mouse tail-vein blood glucose was measured with Free Style Lite (Abbott Diabetes Care, Wiesbaden, Germany).
Real-time polymerase chain reaction
Isolation of total RNA and synthesis of cDNA were performed as described previously [21] . Real-time polymerase chain reaction (PCR) was run using the LightCycler 480 SYBR Green I Master Kit (Roche, Madison, WI, USA) and the thermocycler qTOWER 2.2 (Analytik Jena, Jena, Germany) as described in Hammerschmidt et al. [15] . The sequences of the primer pairs and associated annealing temperatures are listed in Table 1 . The relative gene expression was calculated as described elsewhere (n ¼ 6) [22] .
Histology and immunohistochemistry
Stainings were done with 2-mm paraffin kidney sections. Sections were deparaffinized and exposed to heat-mediated antigen retrieval in citrate buffer (pH 6.0). Endogenous peroxidases were inactivated with 3% H 2 O 2 (Carl Roth, Karlsruhe, Germany) for 10 min at room temperature. As primary antibodies, rabbit anti-MORG1 (Biotrend, Berlin, Germany), rabbit anti-PHD3 (Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-TGF-b1, rabbit anti-E-cadherin (Cell Signaling, Danvers, MA, USA), rabbit anti-PHD1 (Bioss, Woburn, MA, USA), rabbit anti-PHD2 (Novusbio, Abingdon, UK), rabbit anti-collagen I, rabbit anti-fibronectin, rabbit anti-connective tissue growth factor (CTGF), goat anti-SNAI1 and rabbit antia-smooth muscle actin (SMA) (Abcam, Cambridge, UK) were used. Sections were incubated with the peroxidase-labeled goat anti-rabbit or rabbit anti-goat IgG antibody (KPL, Gaithersburg, MD, USA). For imaging, a computer-assisted microscope with a digital camera and AxioVision 4.8 software was used (Zeiss, Jena, Germany). For documentation and quantification, 10 non-overlapping pictures (magnification Â400) per animal (n ¼ 8) were taken and immunohistochemistry was analysed using the scoring system: 0 ¼ no staining, 5 ¼ intense staining. For SNAI1, the number of positive nuclei per field was counted.
For the periodic acid-Schiff (PAS) reaction, the paraffin kidney sections were deparaffinized. Stainings were performed according to the manufacturer's instructions (PAS staining kit, Carl Roth). The degree of mesangial matrix expansion and glomerular sclerosis was determined by adopting the semiquantitative scoring systems proposed by el Nahas et al. [23] . The score was obtained as the mean of at least 40 glomeruli in each animal. The severity of matrix expansion was expressed on an arbitrary scale from 0 to 4 with an individual glomeruli score as follows: Grade 0: normal glomerulus, Grade 4: global sclerosis >75%, global extracapillary fibrosis or complete collapse of the glomerular tuft. Tubular histological injuries were scored as follows: 0 ¼ no changes, 5 ¼ marked changes (n ¼ 8). 
HIF-1a and HIF-2a protein expression and localization were analysed with 2-mm paraffin kidney sections. The deparaffinized kidney sections were exposed to heat-mediated antigen retrieval in citrate buffer (pH 6.0). For immunofluorescence detection, the following antibodies were used: anti-HIF1-a [EPR16897] (Abcam), anti-HIF2-a (GeneTex, Irvine, CA, USA) and Cy TM 3 goat anti-rabbit IgG (HþL) conjugate (Invitrogen, Darmstadt, Germany). Imaging and analysis of pictures (using the scoring system) were done as described for immunohistochemistry. The number of HIF-1a-and HIF-2a-positive nuclei per field was counted (n ¼ 8).
For co-localization studies of SNAI-1 with platelet-derived growth factor receptor (PDGFR), deparaffinized and rehydrated kidney sections (standard protocols) were blocked with normal goat serum and skim milk (45 min) followed by incubation with polyclonal goat anti-SNAI1 (Abcam) and polyclonal rabbit anti-PDGFR (Cell Signaling Technology, Leiden, The Netherlands) overnight at 4 C. After subsequent washing in Tris buffer (50 mM pH 7.4; 3 Â 5 min) secondary antibodies (donkey anti-rabbit conjugated with Alexa 568 and donkey anti-goat conjugated with Alexa 488; both from Invitrogen, Carlsbad, CA, USA; 1:200) were applied for 60 min. Finally, DAPI (4 0 ,6-diamidino-2-phenylindole) was used to stain nuclei (diluted 1:1000 in distilled water for 5 min). Finally, sections were covered with mowiol and analysed using confocal laser scanning microscopy (LSM Zeiss 710).
Western blot analysis
Protein lysis was done using the ProteoExtract Subcellular Proteome Extraction Kit (Calbiochem, Darmstadt, Germany) according to the manufacturer's instructions for fragmented tissue. Kidney sections were fragmented using the SpeedMill P12 (Analytik Jena). Sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blot analysis were performed as described elsewhere [24] . The following primary antibodies were used: rabbit anti-MORG1 (Biotrend), rabbit anti-PHD3, mouse anti-vinculin, mouse anti-Ac-histone H3 (Santa Cruz Biotechnology), rabbit anti-TGF-b1, rabbit anti-CTGF and goat anti-SNAI1 (Abcam); secondary antibodies were peroxidaselabeled antibody to mouse or rabbit goat IgG (HþL) (KPL). The amount of protein was quantified by densitometry using ImageJ software (Wayne Rasband, National Institutes of Health, Bethesda, MD, USA) and normalized to the loading control.
Statistics
All data are reported as mean 6 SE. Statistical analysis was performed using SPSS statistics (IBM, Armonk, NY, USA).
Results were analysed with the Kruskal-Wallis test for multigroup comparison followed by the Mann-Whitney U test to compare two groups of mice. Differences were considered significant when P 0.05.
R E S U L T S
Baseline characteristics and the renoprotective effect of MORG1 heterozygosity on the development of DN To determine the significance of decreased MORG1 expression on the development of DN, we crossed the db/db mouse with mice that were heterozygous for MORG1. The db/db mouse is a standard model of type 2 diabetes. As expected, all diabetic animals were obese and hyperglycemic compared with their non-diabetic littermates ( Table 2 ). There was no significant difference in the degree of hyperglycemia and obesity between db/dbXMORG1 þ/þ and db/dbXMORG1 þ/À mice, suggesting that deletion of one MORG1 allele does not influence the development of diabetes in this model ( Table 2) .
We assessed the renal function in mice by quantifying 24-h albuminuria and evaluating the renal histopathology, such as mesangial matrix expansion ( Figure 1 ). The analysis of albuminuria showed a significant increase in the urinary albumin:creatinine ratio (uACR) in the db/dbXMORG1 þ/þ animals but not in db/dbXMORG1 þ/À mice compared with the non-diabetic mice of the appropriate genotype ( Figure 1A ). Consistent with this clinical finding, db/dbXMORG1 þ/À mice exhibited significantly less renal histological damage, such as mesangial matrix expansion and glomerular sclerosis, than the diabetic MORG1 wild-types [ Figure 1B (arrows) and C]. Thus, whereas the db/dbXMORG1 þ/þ mice developed significant DN, the db/dbXMORG1 þ/À mice were at least partly protected from DN. þ/À mice compared with the MORG1 wild-type. The type 2 diabetes or the db/db phenotype itself did not influence MORG1 expression (Figure 2A-D) . We have already identified MORG1 as a molecular scaffold that directly binds PHD3 in vitro and in vivo [20] . Therefore, we analysed the expression of PHD3. As expected, the MORG1 þ/À mice showed significantly reduced PHD3 expression compared with the MORG1 wild-type ( Figure 2E-H) . Additionally, decreased PHD3 mRNA as well as protein expression was shown in diabetic mice compared with Table 2 . Baseline characteristics of mice (n = 8)
Influence of MORG1 on the HIF-a/EPO axis in diabetic mice
Blood glucose (mmol/L) 6.5 6 0.10 8.7 6 0.14*** 6.3 6 0.13 8.7 6 0.13** Body weight (g) 22.4 6 2.6 49.3 6 3.4*** 22.3 6 4.0 47.7 6 3.5*** EPO (pg/mL) 7.9 6 0.5 9.3 6 0.7 8.2 6 1.1 12.6 6 2.0** ** P 0.01, ***P 0.001 versus db/m.
the non-diabetic littermates independent of the MORG1 genotype ( Figure 2E-H) . Recently, we showed that MORG1 decreases HIF-mediated reporter gene activity and that this effect is additive by co-expression of PHD3 [20] . So we tested the expression of HIF-1a and HIF-2a. Although HIF-1a expression was significantly increased in diabetic db/dbXMORG1 þ/þ mice compared with the non-diabetic MORG1 þ/þ littermates, a slight numerical decrease in HIF-1a protein expression and significantly reduced mRNA expression were observed in db/dbXMORG1 þ/À mice compared with db/dbXMORG1 þ/þ animals ( Figure 3A-D) . In sharp contrast, the kidneys of the db/dbXMORG1 þ/À animals exhibited a significant increase in the expression of HIF-2a compared with the non-diabetic db/mXMORG1 þ/À and db/ dbXMORG1 þ/þ animals ( Figure 3E-H) . It has been shown that suppression of PHD1 and/or PHD3 has greater effects on HIF-2a than on HIF-1a, while HIF-1a is mainly regulated by PHD2 [25, 26] . Whereas the expression analysis of PHD1 showed no significant changes between the groups (Supplementary data, Figure S1A and B), immunohistochemistry revealed that, similar to PHD3, the expression of PHD2 was lower under diabetic conditions in both genotypes of MORG1 compared with non-diabetic control mice (Supplementary data, Figure S1C and D) . In contrast to PHD3, PHD1 and PHD2 tubular protein expression did not decrease, but in fact even increased in the case of PHD2 when MORG1 was reduced (Supplementary data, Figure S1A-D) . This supports the assumption that MORG1 interacts only with PHD3.
Consistent with previous findings that HIF-2 and not HIF-1 is the primary transcription factor for EPO [27] [28] [29] , diabetic db/ dbXMORG1 þ/À mice with upregulated renal HIF-2a expression also exhibited enhanced serum EPO concentrations whereas the db/db phenotype alone had no significant influence on EPO levels in MORG1 wild-type mice ( Table 2) . As previously described [30] , there was a significant increase in the red blood cell (RBC) count, haematocrit (HCT) and haemoglobin (HGB) in the db/dbXMORG1 þ/þ and db/dbXMORG1 þÀ mice compared with their non-diabetic littermates (Table 3 ). In contrast to the EPO concentrations, there were no differences in these parameters (RBC, HCT and HGB) between db/dbXMORG1 þ/À and db/dbXMORG1
, indicating that this increase is not due to EPO-induced erythropoiesis, but rather due to volume depletion as a consequence of the osmotic polyuria in diabetes [31, 32] . Interestingly, the db/ dbXMORG1 þ/À mice exhibited a significantly lower white blood cell (WBC) count compared with the db/dbXMORG1 þ/þ animals. There were no significant differences in all other haematological parameters between the MORG1 þ/þ and MORG1 þ/À mice, regardless of the diabetic status (Table 3) .
Expression of profibrotic cytokines and ECM are reduced in diabetic MORG1 heterozygous mice TGF-b1, the most potent inducer of pathophysiological processes in DN, modulates ECM protein expression either directly or together with CTGF [33, 34] . As expected, in db/ dbXMORG1 þ/þ kidneys, the expression of the profibrotic cytokines TGF-b1 ( Figure 4A-C) and CTGF ( Figure 4D -G) were significantly increased compared with the non-diabetic db/ mXMORG1 þ/þ animals, whereas that was not the case in the db/dbXMORG1 þ/À mice ( Figure 4A-G) . We next analysed the expression of the ECM proteins collagen type I (Figure 4H-I ) and fibronectin ( Figure 4J-K) . We found that in contrast to the db/dbXMORG1 þ/þ animals, the kidneys from the db/ þ/À mice developed significantly less ECM and fibrosis compared with db/dbXMORG1 þ/þ mice.
EMT-like changes are inhibited in diabetic db/db mice with one deleted MORG1 allele
To further evaluate tubular EMT-like changes (altered SNAI1, E-cadherin and a-SMA) in the diabetic kidney, we analysed mRNA and/or protein expression ( Figure 5 ). SNAI1 is the most prominent EMT transcriptional regulator and is induced by TGF-b1 in tubular epithelial cells [10, 35] . Our results show marked differences regarding SNAI1 expression as well as cellular localization in our mouse model ( Figure 5A-E) . Real-time PCR showed significantly increased mRNA expression in the diabetic mice but significantly less SNAI1 mRNA expression in the db/dbXMORG1 þ/À compared with the db/ dbXMORG1 þ/þ mice ( Figure 5A ). Immunohistochemistry of SNAI1 protein expression showed a significant increase in strong-positive nuclei in the tubular cells of the db/ dbXMORG1 þ/þ mice compared with db/mXMORG1 Figure 5B and D) . Cytoplasmic as well as nuclear staining was significantly reduced in the db/dbXMORG1 þ/À compared with the db/dbXMORG1 þ/þ genotype ( Figure 5B-D) . Western blot analysis of nuclear kidney lysates also demonstrated enhanced þ/þ mice compared with the non-diabetic db/mXMORG1 þ/þ controls, whereas in db/dbXMORG1 þ/À mice, no significant changes in HIF-1a expression were detectable. (D) Renal mRNA expression of HIF-1a. Realtime PCR showed significantly increased HIF-1a mRNA expression in the diabetic MORG1 wild-type mice, but not in the MORG1 þ/À . expression of SNAI1 in the diabetic MORG1 wild-type mice, whereas there was no difference between the diabetic and nondiabetic MORG1 þ/À mice ( Figure 5E ). Consistent with reports that SNAI1 contributes to EMT mainly by acting as an E-cadherin repressor [35] , our analysis showed significant suppression of tubular E-cadherin expression only in diabetic db/dbXMORG1 þ/þ mice compared with non-diabetic db/mXMORG1 þ/þ littermates, whereas E-cadherin expression was significantly increased in db/ dbXMORG1 þ/À mice compared with db/dbXMORG1 þ/þ mice ( Figure 5F -G), suggesting that tubular cells of db/ dbXMORG1 þ/À mice are protected from SNAI1-induced loss of epithelial cell-cell contacts.
Finally, we analysed the expression of a-SMA. Immunohistochemistry demonstrated obvious tubular expression of a-SMA and a high number of a-SMA-positive interstitial cells in db/dbXMORG1 þ/þ mice ( Figure 5H ). Quantification of a-SMA staining showed significantly increased expression in þ/þ mice compared with non-diabetic db/mXMORG1 þ/þ controls. SNAI1 expression was significantly reduced in db/dbXMORG1 þ/À mice compared with db/dbXMORG1 þ/þ mice. (E) Western blot analysis of nuclear kidney extracts. The data showed that for the diabetic MORG1 wild-type mice, SNAI1 increased in the nucleus of renal cells. þ/þ mice showed significantly decreased E-cadherin expression compared with non-diabetic db/mXMORG1 þ/þ littermates, whereas E-cadherin expression was maintained in kidneys from db/dbXMORG1 þ/À mice. (H) Representative images of a-SMA staining. The black-rimmed area highlights the differences in expression between the genotypes. Bars ¼ 50 mm. (I) Quantification of a-SMA showed significantly increased tubular and interstitial expression in diabetic db/dbXMORG1 þ/þ mice compared with the corresponding non-diabetic db/mXMORG1 þ/þ controls, whereas the expression in db/dbXMORG1 þ/À mice was significantly diminished compared with db/dbXMORG1 þ/þ mice. (J) Real-time PCR. The renal mRNA expression of a-SMA was obviously increased in db/dbXMORG1 þ/þ mice, whereas a-SMA mRNA expression was significantly decreased in diabetic MORG1 þ/À mice compared with the diabetic wild-type.
þ/þ animals compared with non-diabetic littermates and significantly reduced expression in db/dbXMORG1 þ/À mice compared with db/dbXMORG1 þ/þ mice ( Figure 5H-I) . Real-time PCR showed numerically increased a-SMA mRNA expression in the diabetic MORG1 wild-type, which was significantly diminished in the db/ dbXMORG1 þ/À mice ( Figure 5J ). In addition, co-staining with the pericyte marker PDGFR and the EMT-inducing transcription factor SNAI1 was shown in tubular and interstitial cells of the diabetic MORG1 þ/þ animals, whereas such events were less numerous in db/dbXMORG1 þ/À mice ( Figure 5K ). Taken together, our data suggest that the diminished interstitial fibrosis in db/dbXMORG1 þ/À mice is presumably a consequence of suppressed EMT-like changes in tubular epithelial cells.
D I S C U S S I O N
DN is increasing in incidence and is the leading cause of endstage renal disease in the industrialized world [36] . There are several reports in the literature investigating the effects of genetic background on the extent of DN in a variety of inbred mouse strains [37] [38] [39] . The natural history of diabetes and the renal manifestations in db/db mice have been described primarily for the C57BLKS/J strain, which shares 84% of its alleles with the common C57BL/6 strain and 16% with the DBA/2J strain [36] . It is well known that the incidence of diabetes and diabetic kidney injury is lower and less severe in db/db mice with a C57BL/6 background than those with a C57BLKS/J background [36, 37, 40] . In our study, we used littermates with an identical mixed genetic background, due to crossing of the MORG1 strain (background C57BL/6J) with the db/db strain (background C57BLKS/J). Breyer et al. [37] summarized studies in the literature examining 24-h albumin excretion in db/db mice on the C57BL/6 as well as on the C57BLKS/J background. Studies with db/db-(C57BL/6) mice showed urinary albumin levels at the lower end of microalbuminuria [41, 42] , which is consistent with levels in our model on the mixed background. Although the risk for developing DN seems to correlate with the degree of hyperglycaemia, there are also limitations in the measurement of glucose in mice [37] . This is generally achieved by determination of fasting blood glucose, but this 24-h fast can activate several physiological counterregulatory mechanisms that obscure the reliability of glucose readings [37] . However, in this study we showed significant albuminuria as well as histological damage in diabetic db/dbXMORG1 þ/þ mice, and both were significantly diminished when MORG1 expression was partially reduced in db/dbXMORG1 þ/À mice. The two diabetic genotypes showed no differences in blood glucose level, suggesting that the renoprotective effects of MORG1 reduction are not due to the normalization of hyperglycaemia. Recently, it has been shown that MORG1 acts as a scaffold protein of PHD3 and it is believed that no interaction with either PHD1 or PHD2 exists [20] . Expression analysis of all PHDs supports this assumption, because in db/mXMORG1 þ/À mice only PHD3 is reduced, whereas the tubular expression of the other PHDs (PHD1 and PHD2) remains unchanged or even increased in the case of reduced MORG1. The induction of PHD2 is most likely a compensatory effect when PHD3 is decreased. Compared with the non-diabetic control mice, the diabetic phenotype seems to have an inhibitory effect on PHD2/PHD3 protein expression. However, PHDs catalyze oxygen-dependent hydroxylation of the specific proline residues in HIF-a for rapid polyubiquitination and subsequent proteasomal degradation [43] . Hypoxia, which represents an early event in DN [44] , increases HIF expression by diminishing PHD activities [43] . As MORG1, together with PHD3, decreases the HIF activity, we analysed the protein expression and nuclear localization of HIF-1a as well as HIF-2a and interestingly we found that in db/dbXMORG1 þ/þ mice, HIF-1a was the main activated enzyme isoform, whereas in diabetic db/dbXMORG1 þ/À kidneys, HIF-2a activity was significantly increased, suggesting different roles of the HIF-a isoforms in the MORG1 genotypes. It has been reported that glucose alone in the absence of hypoxia is not enough to activate the HIF-1a pathway [45] . As the two diabetic genotypes in our study showed the same level of hyperglycaemia, the resulting HIF-1a expression suggests that the MORG1 genotypes must have different sensitivities to diabetes-induced hypoxia and/or different signalling pathways must be activated in db/dbXMORG1 þ/þ /db/ dbXMORG1 þ/À kidneys. We analysed the expression of TGF-b1, which is known to increase HIF-1a accumulation and stability through selective inhibition of PHD2 expression [46] . As expected, we found a diabetes-induced upregulation of TGF-b1 expression in db/ dbXMORG1 þ/þ kidneys and significantly lower expression in db/dbXMORG1 þ/À mice. This provides the explanation for the expression pattern not only for HIF-1a, but also for the fibrosis marker CTGF, collagen type I and fibronectin in our study. The mechanisms underlying the reduced renal TGF-b1 protein expression in MORG1 heterozygous mice are currently not totally clear, but we suppose that EPO may inhibit the activation of TGF-b1 in the kidney of db/dbXMORG1 þ/À mice. This assumption is based on two studies that have demonstrated that TGF-b1 induces its own expression in a pSmad3-dependent manner in renal cells [47] and that EPO treatment suppresses TGF-b1-mediated signalling by inhibiting the phosphorylation and nuclear translocation of Smad3 [48] . Appelhoff et al. [25] described a greater influence of PHD3 on HIF-2a than on HIF1a hydroxylation. These findings correlate with our results for MORG1 heterozygous mice, with significantly decreased PHD3 expression in db/dbXMORG1 þ/À animals associated with increased expression of HIF-2a and EPO levels. Furthermore, our results correspond with molecular genetic studies in mice reporting a dominant role for HIF-2a and not HIF-1a for induction of EPO production [28, 29] . The reduction in PHD3 expression implies increased expression of HIF-2a and EPO production in db/mXMORG1 þ/À mice, but although the hydroxylation of HIF-2a is mainly regulated by PHD3, the other PHDs can also hydroxylate HIF-2a when PHD3 is absent.
One major drawback of our study is that we only describe a correlation or phenomenon and did not identify the molecular mechanism by which the reduction in MORG1 leads to attenuated EMT-like changes. This would require a whole series of additional experiments using an in vitro approach with tubular cells involving either knocking down or overexpressing MORG1 and looking at functional studies such as morphological changes of cultured cells, in vitro assays such as wound healing and invasion assays. In fact, we have started to perform such studies, but we believe that identifying the molecular mechanism(s) of our observations is beyond the scope of this initial article.
Taken together, our results demonstrate that in db/ dbXMORG1 þ/þ mice, the development of DN, including albuminuria and renal fibrosis, may be mediated by an upregulated TGF-b1/HIF-1a signalling axis. In contrast to these findings, we detected significantly fewer markers of DN in db/ dbXMORG1 þ/À mice, suggesting that they are at least partially protected against the development of DN. Potential renoprotective effects have been described for activated HIF-2a and EPO in acute as well as CKD [1, 14, 15, 18, 49, 50] .
We observed results similar to those in the db/db mice in STZ-induced diabetes in MORG1 þ/À mice with significantly less renal histological damage compared with diabetic MORG1 þ/þ mice (data not shown). In this STZ-model, analogous to the db/db model, the heterozygous expression of MORG1 led to increased serum EPO levels under diabetic conditions and the diabetes-induced TGF-b1 expression, seen in the wild-type, was non-existent when MORG1 expression was reduced (data not shown). However, since STZ may exhibit tubular toxicity [37, 38] , we found that the db/dbXMORG1 þ/À cross is a much better model, especially for studying tubule interstitial changes including EMT.
To address whether the detected tubulointerstitial fibrosis in db/dbXMORG1 þ/þ mice may be a consequence of EMT of the tubular cells, we investigated key events in the EMT mechanism: (i) induction of an EMT-activating transcription factor (SNAI1), (ii) reduction of the epithelial cell marker (E-cadherin) and (iii) de novo a-SMA synthesis. We found that EMT-like changes in tubular cells are activated during DN in db/dbXMORG1 þ/þ mice compared with non-diabetic db/ mXMORG1 þ/þ mice, whereas EMT was inhibited in db/ dbXMORG1 þ/À mice. Consistent with our findings, it has been reported that the transcription factor SNAI1, known for its ability to trigger EMT and induction of kidney fibrosis, is activated by TGF-b1 as well as HIF-1a and requires a nuclear localization to induce EMT [35, [51] [52] [53] . Currently, we do not know exactly why SNAl1 expression was significantly reduced in db/ dbXMORG1 þ/À mice compared with db/dbXMORG1 þ/þ animals. But we suggest that slightly enhanced HIF-1a expression in db/dbXMORG1 þ/À mice in contrast to db/dbXMORG1 þ/þ mice compared with the corresponding non-diabetic control and/or the shift to HIF-2a expression in db/dbXMORG1 þ/À may play a role. Furthermore, diminished TGF-b1 expression in db/dbXMORG1 þ/À mice has likely also contributed to reduced tubular SNAl1 expression.
Although some investigators have raised doubts regarding the precise contribution of EMT to the progression of kidney fibrosis [6, 7] , a recent study showed that the contribution of EMT to renal fibrosis differs between renal disease models, the investigated mouse strains and the type of genetic alteration used [47] . In addition, two recent publications have described an intratubular EMT-like programme of epithelial cell dedifferentiation that may contribute to the recruitment or proliferation of interstitial myofibroblasts after kidney injury [3, 9, 10] . Both research teams knocked out the EMT-inducer SNAI1 in tubules and found significant reductions in interstitial fibrosis, which highlighted the importance of an EMT-like programme in renal epithelial cells for the development of fibrosis [3, 9, 10] . Furthermore, the investigators performed lineage tracing of tubular cells and found that the damaged cells remain integrated in the tubules and express markers of both the epithelial and mesenchymal cells while still relaying fibrogenic signals that lead to progression of the disease [9, 10] . In this study, costaining of PDGFR and the EMT-inducing transcription factor SNAI1 was shown in tubular and interstitial cells of diabetic MORG1 þ/þ animals, whereas such events were less numerous in db/dbXMORG1 þ/À mice. This is a strong link between EMT and fibrosis because PDGFR is a marker of pericytes, which are important for fibrosis.
In summary, our results clearly demonstrate that deletion of one MORG1 allele protected the kidney against development of DN and EMT-induced renal fibrosis via activation of HIF-2a and/or EPO. Thus, specific HIF-2a activation might serve as a novel therapeutic strategy for the treatment of DN.
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